LONDON--(BUSINESS WIRE)--Technavio’s global implantable cardioverter defibrillators (ICD) market research report forecasts the market to grow at a CAGR of almost 2% during the forecast period. The ...

In patients younger than 19 with implantable cardioverter defibrillators, a lower body weight, indicating younger age, is ...

The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...

Boston Scientific has begun a clinical trial of its first modular cardiac rhythm implant system. It consists of a leadless pacemaker and an implantable cardioverter defibrillator—two separate devices ...

Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...

Most patients with ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) who have an implantable cardioverter-defibrillator (ICD) now live more than seven years and those ICD patients with ...

1 in 5 with implantable cardioverter-defibrillator don't meet criteria for use. Jan. 4, 2011— -- One in five patients who receive the heart-shocking, life-saving devices known as implantable ...

A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the device is inserted, ...

Medtronic has received U.S. regulatory approval to sell a new implantable defibrillator that can be placed outside of the heart and veins to treat SCA — sudden cardiac arrest — an electrical problem ...

Implantable cardioverter defibrillators are devices implanted in a patient’s chest with the ability to terminate ventricular arrhythmias. Termination of these ventricular arrhythmias is vital to ...